# Ernexa Therapeutics Inc.: Form SCHEDULE 13D/A, filed Mar 5, 2025

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-05
- Accepted by EDGAR: Mar 5, 2025, 17:55 ET
- Period: not reported
- Accession: 0001104659-25-020984
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000110465925020984/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000110465925020984/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000110465925020984/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-020984. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.